Literature DB >> 30263871

Transcriptomic and epigenomic differences in human induced pluripotent stem cells generated from six reprogramming methods.

Jared M Churko1,2,3, Jaecheol Lee1,2,3, Mohamed Ameen1,2,3, Mingxia Gu1,2,3, Meenakshi Venkatasubramanian4, Sebastian Diecke1,2,3, Karim Sallam1,2,3, Hogune Im4, Gavin Wang5, Joseph D Gold1, Nathan Salomonis4, Michael P Snyder5, Joseph C Wu6,7,8.   

Abstract

Many reprogramming methods can generate human induced pluripotent stem cells (hiPSCs) that closely resemble human embryonic stem cells (hESCs). This has led to assessments of how similar hiPSCs are to hESCs, by evaluating differences in gene expression, epigenetic marks and differentiation potential. However, all previous studies were performed using hiPSCs acquired from different laboratories, passage numbers, culturing conditions, genetic backgrounds and reprogramming methods, all of which may contribute to the reported differences. Here, by using high-throughput sequencing under standardized cell culturing conditions and passage number, we compare the epigenetic signatures (H3K4me3, H3K27me3 and HDAC2 ChIP-seq profiles) and transcriptome differences (by RNA-seq) of hiPSCs generated from the same primary fibroblast population by using six different reprogramming methods. We found that the reprogramming method impacts the resulting transcriptome and that all hiPSC lines could terminally differentiate, regardless of the reprogramming method. Moreover, by comparing the differences between the hiPSC and hESC lines, we observed a significant proportion of differentially expressed genes that could be attributed to polycomb repressive complex targets.

Entities:  

Year:  2017        PMID: 30263871      PMCID: PMC6155993          DOI: 10.1038/s41551-017-0141-6

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  42 in total

1.  Circos: an information aesthetic for comparative genomics.

Authors:  Martin Krzywinski; Jacqueline Schein; Inanç Birol; Joseph Connors; Randy Gascoyne; Doug Horsman; Steven J Jones; Marco A Marra
Journal:  Genome Res       Date:  2009-06-18       Impact factor: 9.043

2.  Lentiviral vector design and imaging approaches to visualize the early stages of cellular reprogramming.

Authors:  Eva Warlich; Johannes Kuehle; Tobias Cantz; Martijn H Brugman; Tobias Maetzig; Melanie Galla; Adam A Filipczyk; Stephan Halle; Hannes Klump; Hans R Schöler; Christopher Baum; Timm Schroeder; Axel Schambach
Journal:  Mol Ther       Date:  2011-02-01       Impact factor: 11.454

3.  A more efficient method to generate integration-free human iPS cells.

Authors:  Keisuke Okita; Yasuko Matsumura; Yoshiko Sato; Aki Okada; Asuka Morizane; Satoshi Okamoto; Hyenjong Hong; Masato Nakagawa; Koji Tanabe; Ken-ichi Tezuka; Toshiyuki Shibata; Takahiro Kunisada; Masayo Takahashi; Jun Takahashi; Hiroh Saji; Shinya Yamanaka
Journal:  Nat Methods       Date:  2011-04-03       Impact factor: 28.547

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.

Authors:  Ning Sun; Masayuki Yazawa; Jianwei Liu; Leng Han; Veronica Sanchez-Freire; Oscar J Abilez; Enrique G Navarrete; Shijun Hu; Li Wang; Andrew Lee; Aleksandra Pavlovic; Shin Lin; Rui Chen; Roger J Hajjar; Michael P Snyder; Ricardo E Dolmetsch; Manish J Butte; Euan A Ashley; Michael T Longaker; Robert C Robbins; Joseph C Wu
Journal:  Sci Transl Med       Date:  2012-04-18       Impact factor: 17.956

6.  Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.

Authors:  Frederick Anokye-Danso; Chinmay M Trivedi; Denise Juhr; Mudit Gupta; Zheng Cui; Ying Tian; Yuzhen Zhang; Wenli Yang; Peter J Gruber; Jonathan A Epstein; Edward E Morrisey
Journal:  Cell Stem Cell       Date:  2011-04-08       Impact factor: 24.633

7.  Sodium butyrate promotes generation of human induced pluripotent stem cells through induction of the miR302/367 cluster.

Authors:  Zhonghui Zhang; Wen-Shu Wu
Journal:  Stem Cells Dev       Date:  2013-04-27       Impact factor: 3.272

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  ToppGene Suite for gene list enrichment analysis and candidate gene prioritization.

Authors:  Jing Chen; Eric E Bardes; Bruce J Aronow; Anil G Jegga
Journal:  Nucleic Acids Res       Date:  2009-05-22       Impact factor: 16.971

10.  Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.

Authors:  Danwei Huangfu; René Maehr; Wenjun Guo; Astrid Eijkelenboom; Melinda Snitow; Alice E Chen; Douglas A Melton
Journal:  Nat Biotechnol       Date:  2008-06-22       Impact factor: 54.908

View more
  14 in total

Review 1.  Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models.

Authors:  Alexa Wnorowski; Huaxiao Yang; Joseph C Wu
Journal:  Adv Drug Deliv Rev       Date:  2018-06-06       Impact factor: 15.470

2.  High-throughput Preparation of DNA, RNA, and Protein from Cryopreserved Human iPSCs for Multi-omics Analysis.

Authors:  Jeffrey X Zhang; Edward Lau; David T Paik; Yan Zhuge; Joseph C Wu
Journal:  Curr Protoc Stem Cell Biol       Date:  2020-09

Review 3.  Huntington's disease iPSC models-using human patient cells to understand the pathology caused by expanded CAG repeats.

Authors:  Julia Kaye; Terry Reisine; Steven Finkbeiner
Journal:  Fac Rev       Date:  2022-06-28

Review 4.  Building gut from scratch - progress and update of intestinal tissue engineering.

Authors:  Lucinda Tullie; Brendan C Jones; Paolo De Coppi; Vivian S W Li
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-03-03       Impact factor: 73.082

5.  Systems-Wide Approaches in Induced Pluripotent Stem Cell Models.

Authors:  Edward Lau; David T Paik; Joseph C Wu
Journal:  Annu Rev Pathol       Date:  2018-10-31       Impact factor: 23.472

Review 6.  Human-induced pluripotent stem cells in cardiovascular research: current approaches in cardiac differentiation, maturation strategies, and scalable production.

Authors:  Dilip Thomas; Nathan J Cunningham; Sushma Shenoy; Joseph C Wu
Journal:  Cardiovasc Res       Date:  2022-01-07       Impact factor: 10.787

Review 7.  Metabolomics Analysis of Mesenchymal Stem Cells.

Authors:  Parisa Goodarzi; Sepideh Alavi-Moghadam; Moloud Payab; Bagher Larijani; Fakher Rahim; Kambiz Gilany; Nikoo Bana; Akram Tayanloo-Beik; Najmeh Foroughi Heravani; Mahdieh Hadavandkhani; Babak Arjmand
Journal:  Int J Mol Cell Med       Date:  2019-06-20

8.  DoubletDecon: Deconvoluting Doublets from Single-Cell RNA-Sequencing Data.

Authors:  Erica A K DePasquale; Daniel J Schnell; Pieter-Jan Van Camp; Íñigo Valiente-Alandí; Burns C Blaxall; H Leighton Grimes; Harinder Singh; Nathan Salomonis
Journal:  Cell Rep       Date:  2019-11-05       Impact factor: 9.423

9.  A non-invasive method to generate induced pluripotent stem cells from primate urine.

Authors:  Johanna Geuder; Lucas E Wange; Aleksandar Janjic; Jessica Radmer; Philipp Janssen; Johannes W Bagnoli; Stefan Müller; Artur Kaul; Mari Ohnuki; Wolfgang Enard
Journal:  Sci Rep       Date:  2021-02-10       Impact factor: 4.379

10.  cellHarmony: cell-level matching and holistic comparison of single-cell transcriptomes.

Authors:  Erica A K DePasquale; Daniel Schnell; Phillip Dexheimer; Kyle Ferchen; Stuart Hay; Kashish Chetal; Íñigo Valiente-Alandí; Burns C Blaxall; H Leighton Grimes; Nathan Salomonis
Journal:  Nucleic Acids Res       Date:  2019-12-02       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.